U.S. flag

An official website of the United States government

NM_207361.6(FREM2):c.2206C>T (p.Arg736Ter) AND not provided

Germline classification:
Pathogenic (3 submissions)
Last evaluated:
Nov 14, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001702715.4

Allele description [Variation Report for NM_207361.6(FREM2):c.2206C>T (p.Arg736Ter)]

NM_207361.6(FREM2):c.2206C>T (p.Arg736Ter)

Gene:
FREM2:FRAS1 related extracellular matrix 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q13.3
Genomic location:
Preferred name:
NM_207361.6(FREM2):c.2206C>T (p.Arg736Ter)
HGVS:
  • NC_000013.11:g.38689550C>T
  • NG_008125.2:g.7515C>T
  • NM_207361.6:c.2206C>TMANE SELECT
  • NP_997244.4:p.Arg736Ter
  • NC_000013.10:g.39263687C>T
  • NM_207361.5:c.2206C>T
Protein change:
R736*; ARG736TER
Links:
OMIM: 608945.0006; dbSNP: rs939534674
NCBI 1000 Genomes Browser:
rs939534674
Molecular consequence:
  • NM_207361.6:c.2206C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001928261Genome Diagnostics Laboratory, University Medical Center Utrecht - VKGL Data-share Consensus

See additional submitters

no assertion criteria provided
Pathogenicgermlineclinical testing

SCV001974942Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center - VKGL Data-share Consensus

See additional submitters

no assertion criteria provided
Pathogenicgermlineclinical testing

SCV004509492Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 14, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Fraser syndrome due to homozygosity for a splice site mutation of FREM2.

Shafeghati Y, Kniepert A, Vakili G, Zenker M.

Am J Med Genet A. 2008 Feb 15;146A(4):529-31. doi: 10.1002/ajmg.a.32091. No abstract available.

PubMed [citation]
PMID:
18203166

Prenatal diagnosis of Fraser syndrome: a matter of life or death?

De Bernardo G, Giordano M, Di Toro A, Sordino D, De Brasi D.

Ital J Pediatr. 2015 Nov 9;41:86. doi: 10.1186/s13052-015-0195-6.

PubMed [citation]
PMID:
26552811
PMCID:
PMC4640198
See all PubMed Citations (4)

Details of each submission

From Genome Diagnostics Laboratory, University Medical Center Utrecht - VKGL Data-share Consensus, SCV001928261.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center - VKGL Data-share Consensus, SCV001974942.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004509492.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change creates a premature translational stop signal (p.Arg736*) in the FREM2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FREM2 are known to be pathogenic (PMID: 18203166, 26552811). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with clinical features of Fraser syndrome (PMID: 30802441). ClinVar contains an entry for this variant (Variation ID: 625182). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024